These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
551 related articles for article (PubMed ID: 25598425)
1. Advanced research on vasculogenic mimicry in cancer. Qiao L; Liang N; Zhang J; Xie J; Liu F; Xu D; Yu X; Tian Y J Cell Mol Med; 2015 Feb; 19(2):315-26. PubMed ID: 25598425 [TBL] [Abstract][Full Text] [Related]
2. The relationship between vasculogenic mimicry and epithelial-mesenchymal transitions. Liu Q; Qiao L; Liang N; Xie J; Zhang J; Deng G; Luo H; Zhang J J Cell Mol Med; 2016 Sep; 20(9):1761-9. PubMed ID: 27027258 [TBL] [Abstract][Full Text] [Related]
3. [Research progress in vasculogenic mimicry in multiple tumors]. Bai J; Xu Z; Liao C; Yang L Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):357-364. PubMed ID: 28364113 [TBL] [Abstract][Full Text] [Related]
4. The hypoxia-related signaling pathways of vasculogenic mimicry in tumor treatment. Li S; Meng W; Guan Z; Guo Y; Han X Biomed Pharmacother; 2016 May; 80():127-135. PubMed ID: 27133049 [TBL] [Abstract][Full Text] [Related]
7. Epithelial Mesenchymal Transition and Vascular Mimicry in Breast Cancer Stem Cells. Kotiyal S; Bhattacharya S Crit Rev Eukaryot Gene Expr; 2015; 25(3):269-80. PubMed ID: 26558950 [TBL] [Abstract][Full Text] [Related]
8. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype. Yao L; Zhang D; Zhao X; Sun B; Liu Y; Gu Q; Zhang Y; Zhao X; Che N; Zheng Y; Liu F; Wang Y; Meng J J Cell Mol Med; 2016 Sep; 20(9):1673-85. PubMed ID: 27240974 [TBL] [Abstract][Full Text] [Related]
9. Epithelial-to-endothelial transition and cancer stem cells: two cornerstones of vasculogenic mimicry in malignant tumors. Sun B; Zhang D; Zhao N; Zhao X Oncotarget; 2017 May; 8(18):30502-30510. PubMed ID: 27034014 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Wei X; Chen Y; Jiang X; Peng M; Liu Y; Mo Y; Ren D; Hua Y; Yu B; Zhou Y; Liao Q; Wang H; Xiang B; Zhou M; Li X; Li G; Li Y; Xiong W; Zeng Z Mol Cancer; 2021 Jan; 20(1):7. PubMed ID: 33397409 [TBL] [Abstract][Full Text] [Related]
11. Regulatory mechanisms and therapeutic targeting of vasculogenic mimicry in hepatocellular carcinoma. Zheng N; Zhang S; Wu W; Zhang N; Wang J Pharmacol Res; 2021 Apr; 166():105507. PubMed ID: 33610718 [TBL] [Abstract][Full Text] [Related]
12. Vasculogenic mimicry, a complex and devious process favoring tumorigenesis - Interest in making it a therapeutic target. Treps L; Faure S; Clere N Pharmacol Ther; 2021 Jul; 223():107805. PubMed ID: 33465401 [TBL] [Abstract][Full Text] [Related]
13. Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer. Li Y; Sun B; Zhao X; Zhang D; Wang X; Zhu D; Yang Z; Qiu Z; Ban X Exp Mol Pathol; 2015 Apr; 98(2):136-44. PubMed ID: 25661888 [TBL] [Abstract][Full Text] [Related]
15. Vasculogenic mimicry in carcinogenesis and clinical applications. Luo Q; Wang J; Zhao W; Peng Z; Liu X; Li B; Zhang H; Shan B; Zhang C; Duan C J Hematol Oncol; 2020 Mar; 13(1):19. PubMed ID: 32169087 [TBL] [Abstract][Full Text] [Related]
16. Slug promoted vasculogenic mimicry in hepatocellular carcinoma. Sun D; Sun B; Liu T; Zhao X; Che N; Gu Q; Dong X; Yao Z; Li R; Li J; Chi J; Sun R J Cell Mol Med; 2013 Aug; 17(8):1038-47. PubMed ID: 23815612 [TBL] [Abstract][Full Text] [Related]
17. Contribution of cancer stem cells to tumor vasculogenic mimicry. Yao XH; Ping YF; Bian XW Protein Cell; 2011 Apr; 2(4):266-72. PubMed ID: 21533771 [TBL] [Abstract][Full Text] [Related]
18. Down-regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP-2 and inducing mesenchymal-to-epithelial transition. Zhang W; Zhou P; Meng A; Zhang R; Zhou Y J Cell Mol Med; 2018 Mar; 22(3):1743-1754. PubMed ID: 29164766 [TBL] [Abstract][Full Text] [Related]
19. Exploring stemness gene expression and vasculogenic mimicry capacity in well- and poorly-differentiated hepatocellular carcinoma cell lines. Lirdprapamongkol K; Chiablaem K; Sila-Asna M; Surarit R; Bunyaratvej A; Svasti J Biochem Biophys Res Commun; 2012 Jun; 422(3):429-35. PubMed ID: 22580004 [TBL] [Abstract][Full Text] [Related]
20. Vasculogenic mimicry: Possible role of effector caspase-3, caspase-6 and caspase-7. Linder M; Tschernig T Ann Anat; 2016 Mar; 204():114-7. PubMed ID: 26704356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]